Clinicopathological Characteristics of Inflammatory Myofibroblastic Tumor: A Single Center Retrospective Cohort Study
The most common site of IMT is the lung. Surgery is the main treatment for IMT, and postoperative adjuvant therapy for ALK-positive patients needs to be focused. The molecular testing is essential for all patients diagnosed with IMTs. Systemic treatment needs further research.
Authors
- Hanping Wang (ORCID: https://orcid.org/0000-0003-3540-2280)
- Shafei Wu (ORCID: https://orcid.org/0000-0003-2570-6280)
- Kai‐Feng Xu (ORCID: https://orcid.org/0000-0002-7662-531X)
- Xiaoyan Si (ORCID: https://orcid.org/0000-0003-2913-3045)
- Xiaotong Zhang (ORCID: https://orcid.org/0000-0001-8937-820X)
- Li Zhang (ORCID: https://orcid.org/0000-0002-8101-672X)
- Ruie Feng (ORCID: https://orcid.org/0000-0002-1609-9901)
- Mengzhao Wang (ORCID: https://orcid.org/0000-0003-1685-1515)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1111/1759-7714.15496
- Citations
- 3
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Peking Union Medical College Hospital